Rifadin Iv
Product Images NDC 0068-0597

2 FDA label images from Sanofi-aventis U.s. Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Rifadin Iv (NDC 0068-0597). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sanofi-aventis U.s. Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (036ab68e 5085 4edc Bd83 784b43d64eab 01)

Chemical Structure (036ab68e 5085 4edc Bd83 784b43d64eab 01)
Chemical structure of the active ingredient in Rifadin IV, showing a complex molecular formula with multiple rings, hydroxyl groups, and amide linkages consistent with the rifampin molecule.*
FDA Label Image

Principal Display Panel (600 mg Vial Carton)

Principal Display Panel (600 mg Vial Carton)
Packaging label for Rifadin IV 600 mg/vial, rifampin for injection USP, sterile vial for IV infusion only. The label includes dosage and storage information, barcode, and is manufactured by Sanofi-Aventis U.S. LLC. The NDC is 0068-0597-01. The package design is cream-colored with green and brown text.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.